Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon

Abstract

Iloprost and alprostadil were both of benefit in CTD-associated RP, without significant differences in either clinical efficacy or circulating markers. However, ease of handling and the lower price favours alprostadil.